Global EP Summit to Provide an Essential Electrophysiology Update This September

For the latest practice insights across the spectrum of electrophysiology (EP) care, there is no better forum this year than the Global EP Summit 2022, held Sept. 23-24 at the Hilton Cleveland Downtown.

At the 1.5-day CME-certified symposium, global leaders in EP research and clinical practice will share the most recent developments in the field to help electrophysiologists and other cardiovascular clinicians keep their practice current and maximally beneficial to patients. The course is developed and directed by Cleveland Clinic with co-sponsorship by the Heart Rhythm Society.

“This year marks our fourth offering of this summit and the first in-person offering since the inaugural summit in 2019,” says summit co-director Walid Saliba, MD, Director of Cleveland Clinic’s Electrophysiology Lab. “We will explore current challenges and leading practices in the management of atrial fibrillation (AF), ventricular tachycardia (VT), ventricular fibrillation and other arrhythmia-based syndromes using a mix of sessions from past years and new sessions providing additional perspectives on practice and research.”

Dozens of experts on tap

This year’s iteration of the summit features the largest faculty to date, with more than 40 experts from Cleveland Clinic, other leading U.S. institutions, and top centers in Canada and Europe. Among them are numerous renowned EP practitioners as well as basic science researchers and specialists in cardiac surgery, heart failure cardiology and vascular neurology.

“We want to bring together EP experts not just to discuss the newest developments but also to drive innovation and collaboration in our field worldwide,” notes summit co-director Oussama Wazni, MD, MBA, Section Head of Cardiac Electrophysiology and Pacing at Cleveland Clinic.

The summit will provide opportunities for interaction with faculty via Q&A segments and/or panel discussions at the end of each of its seven themed sessions, which otherwise consist of briskly paced 10-minute overviews of well-focused topics.

Content at a glance

Over a day and a half (a full Friday plus Saturday morning), sessions will address the following:

• Hot topics in AF ablation, including early ablation, the current status of pulsed-field ablation, ablation of persistent AF, AF ablation for heart failure with preserved ejection fraction, high-density mapping in various contexts and more
• Stroke prevention in AF, covering screening for stroke risk, the role of genetics, personalized stroke prevention and multiple aspects of left atrial appendage (LAA) closure
• Recorded cases of pulsed-field ablation and LAA occlusion procedures using various devices
• Ventricular arrhythmia management, including substrate mapping for VT, activation mapping for hemodynamically nontolerated VT, new targets for ablation, VT ablation in nonischemic cardiomyopathy, and more, as well as a 30-minute roundtable discussion on multidisciplinary collaboration for VT management
• New advances in device management, covering various issues in lead extraction, new device technologies, conduction system anatomy, physiologic pacing, and treating and preventing device infection
• Innovations in EP, from optical mapping of AF to the role of artificial intelligence/big data to new energy sources and more
• Cleveland Clinic EP in action, involving discussions of challenging cases across the spectrum of EP care

“The latter session, which concludes the summit late Saturday morning, is new this year and will likely be a highlight,” says summit co-director Shady Nakhla, MD, a staff electrophysiologist at Cleveland Clinic. “It also includes a discussion of how to strive to build the world’s finest EP program. That is emblematic of what this course aims to do — help attendees leave with information and guidance on how to improve their EP program and EP practice right away.”

For more details and registration, visit ccfcme.org/globalep22. Early-bird pricing ends Aug. 1.

This activity has been approved for AMA PRA Category 1 Credit™.